Black Church Treatment Study
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04580810 |
|
Recruitment Status :
Recruiting
First Posted : October 8, 2020
Last Update Posted : November 9, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
This study will conduct a randomized clinical trial comparing levels of treatment initiation, engagement, and alcohol outcomes for a novel treatment strategy (CBT4CBT delivered in the Black church) compared with traditional outpatient specialty addiction treatment for a large sample of Black adults with AUD.
The purpose of this randomized clinical trial is to determine which setting (church or specialty clinic) (1) has better treatment initiation and retention rates and (2) better AUD outcomes as measured by percentage of days abstinent (PDA) (8 weeks, 3, 6 and 9 months follow up).
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Alcohol Use Disorder | Behavioral: CBT4CBT in the Black Church | Not Applicable |
This study is a randomized control trial focusing on rates of treatment initiation, engagement, and outcome in Black adults assigned to CBT4CBT in the Black Church relative to the standard of care for this population. This study is focusing on individuals with AUD as the needs assessment indicated that as the most common substance use problem in this setting. Moreover, our focus groups and work with Church staff has indicated that alcohol use is less stigmatized within the Black and the Church communities than other substance use. Thus, while individuals with other substance use will be included, positioning the study as focusing primarily on alcohol use will avoid potential issues of stigma and thus may facilitate recruitment.
Selecting a comparison condition for this novel intervention strategy is complex.
As the primary rationale for delivering treatment in the Black church setting is that this national network is seen as a trusted institution in the Black community, our research questions center around (1) whether delivering CBT4CBT in the Black church is a safe and effective alternative to standard care, (2) whether it engages and retains individuals better than standard specialty care, (3) the extent to which this strategy reaches individuals who would not otherwise seek treatment for AUD, (4) what kinds of individuals are particularly suited to this setting, and (5) the relative costs of this novel form of treatment delivery. Thus, a standard specialty care at Midwestern Connecticut Council on Alcohol (MCCA) as the comparison condition was selected. MCCA is a non-profit, community-based provider in the predominantly Black Dixwell neighborhood, not far from Dixwell Church and has a positive reputation in the Black community. The primary treatment modality is group therapy. In 2019, MCCA treated over 500 unique individuals (44% female, 35% African American, 20% Latino). MCCA staff are diverse and multidisciplinary. Clinic Director Steven Palma has agreed to provide a dedicated triage slot for this study so individuals can be admitted and assigned a group within one week, reducing a key barrier.
The two study settings will be balanced in several ways, with few barriers to care, both in the same neighborhood, and assignment of participants to a group within one week of randomization, thus preserving equipoise and balancing attractiveness of both sites to participants as much as possible. They will differ primarily in setting (church versus specialty care), in treatment content (CBT4CBT with spirituality elements versus group treatment with some CBT content), and group leaders (CHAs versus masters-level staff).
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 200 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Treatment |
| Official Title: | Addressing Health Disparities by Providing Evidence-Based Treatment in the Black Church |
| Actual Study Start Date : | July 7, 2021 |
| Estimated Primary Completion Date : | June 1, 2024 |
| Estimated Study Completion Date : | July 31, 2025 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: CBT4CBT in the Black Church
The 'CBT for CBT' program is modeled closely on our NIDA-published CBT manual. Seven core skill modules will cover the following topics, which correspond to the major session topics in the manual: Understanding and changing patterns of alcohol use, Coping with craving, Substance refusal skills, Seemingly irrelevant decisions, Planning for emergencies, and Problem-solving skills. Staying Safe |
Behavioral: CBT4CBT in the Black Church
Use of Computer Based Treatment for Cognitive Behavioral Therapy for alcohol use disorder offered in a Black church setting |
|
No Intervention: Community Based Treatment as Usual
Treatment as usual, typically groups, offered by a specialty community based treatment center (MCCA)
|
- Rates of treatment initiation [ Time Frame: 8 weeks ]Rates of treatment initiation as measured by proportion of participants completing at least one session at the assigned site
- Rates of engagement in treatment [ Time Frame: 8 weeks ]Rates of engagement in treatment operationalized by proportion retained at the 4-week point at the assigned site
- Percent days abstinent from alcohol [ Time Frame: 8 weeks ]Percent days abstinent from alcohol operationalized by Timeline Follow Back
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- at least 18 years of age
- current AUD as their principal substance use disorder, confirmed via MINI100 interview, with some drinking in the past 28 days
- English-speaking
Exclusion Criteria:
- inability to provide informed consent or participate in the study procedures as proposed in the consent
- active suicidal or homicidal ideation or an unstable psychotic disorder (schizophrenia, schizoaffective disorder) or mood disorder (bipolar disorder, severe major depressive disorder),
- current engagement in substance use treatment, and
- an unwillingness to be randomized to either condition. Individuals with comorbid substance use disorders will be included, as multiple substances of use are common in this population.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04580810
| Contact: Ayana Jordan, MD, PhD | 203-787-5839 | Ayana.Jordan@nyulangone.org |
| United States, Connecticut | |
| Dixwell Ave Congregational United Church of Christ | Recruiting |
| New Haven, Connecticut, United States, 06511 | |
| Contact: Fredrick Streets 203-787-5839 ayana.jordan@yale.edu | |
| Midwestern Connecticut Council on Alcoholism (McCa) | Not yet recruiting |
| New Haven, Connecticut, United States, 06511 | |
| Contact: Steve Palmer 203-285-6475 | |
| Principal Investigator: | Ayana Jordan, MD, PhD. | NYU Langone Health |
| Responsible Party: | NYU Langone Health |
| ClinicalTrials.gov Identifier: | NCT04580810 |
| Other Study ID Numbers: |
21-01366 R01AA028778-01 ( U.S. NIH Grant/Contract ) |
| First Posted: | October 8, 2020 Key Record Dates |
| Last Update Posted: | November 9, 2021 |
| Last Verified: | November 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Alcoholism Alcohol-Related Disorders Substance-Related Disorders Chemically-Induced Disorders Mental Disorders |

